CClinicalTrials.gg
CompletedNCT04448041CRANEUpdated Jun 7, 2024

CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries

An observational study in Malnutrition, Surgery and Cancer, sponsored by University of Edinburgh. Completed at 11 sites in 3 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-06-07.

Sponsored by University of Edinburgh · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
168
Ages
18 Years and older
Sex
All
01

Study summary

Aims: The CRANE feasibility study (A mixed methods study of malnutrition and sustainable nutritional intervention for patients undergoing cancer surgery in low- and middle-income countries) aims to investigate the identification of pre-operative malnourishment, data collection methods and acceptability of a nutritional intervention for a future trial to improve outcomes after cancer surgery in low- and middle-income countries (LMICs).

  1. To identify and validate the most relevant nutritional screening tool for patients in LMICs undergoing surgery for cancer;
  2. To identify a low cost sustainable nutritional intervention for patients in LMICs undergoing surgery for cancer;
  3. To establish the feasibility of delivering a randomised trial of a sustainable nutritional intervention for patients in LMICs undergoing surgery for cancer.

Design: A mixed-methods study comprising of qualitative work including focus groups and interviews, trial of data collection and validation to test feasibility in clinical practice

Participants: Patients undergoing elective surgery for suspected cancer in LMICs

Outcomes Work package (WP) 1: The primary deliverable is the identification of a relevant, pragmatic, and acceptable nutritional screening tool.

WP 2: The primary deliverable is the identification of a low-cost and sustainable nutritional intervention. Focus groups and interviews will be held with patients and clinicians to explore the sustainability, implementation and acceptability of screening and interventions.

WP 3: The primary outcome will be to determine feasibility and acceptability of trial design. A number of outcome assessments and data collection instruments will be evaluated for feasibility, including anthropometric parameters and patient outcomes (30-day mortality, major post-operative complications, length of hospital stay and quality of life). A final study design, analysis plan, and health economic plan will be developed.

Sample size: For this feasibility study, the investigators will conduct multidisciplinary focus groups and interviews, perform and validate malnutrition screening in 200 patients across four countries and record patient 30-day outcomes. This will also include the time taken to collect data on 200 eligible patients. This sample size has been informed from previous malnutrition data originating from a large prospective international multicentre observational cancer study (GlobalSurg 3).

02

Conditions studied

  • Malnutrition
  • Surgery
  • Cancer

Browse trials for

Keywords

  • Malnutrition
  • Screening tools
  • Cancer surgery
  • Low and middle-income countries (LMIC)
03

In context

Malnutrition

1,587 studies on the registry are indexed under Malnutrition; 237 are open to participants now.

This study's enrollment of 168 is below the median of 203 across 388 observational studies indexed under Malnutrition.

Browse Malnutrition studies →

Lead sponsor

University of Edinburgh is the lead sponsor of 393 studies on the registry; 64 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients undergoing surgery for cancer in four partner LMIC countries are eligible

Inclusion criteria

  • Hospitals in LMICs who undertake planned (elective) cancer surgery for cancer.
  • Patients over 18 years of age (or the age of majority for the country);
  • Patients undergoing planned (elective) surgery for cancer;
  • Patients undergoing surgery where the intent is either curative or palliative;
  • Patients must be able and willing to provide written informed consent (signature or a fingerprint).

Exclusion criteria

Exclusion Criteria:

  • Children (below age of majority for the country);
  • Patients undergoing emergency surgery;
  • Any operative indication other than cancer;
  • Patients unable to provide written informed consent;
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
168 participants (actual)
Patient registry
No

Groups and cohorts

  • Ghana

    Other: Malnutrition screening

  • India

    Other: Malnutrition screening

  • Philippines

    Other: Malnutrition screening

  • Zambia

    Other: Malnutrition screening

Interventions

  • OtherMalnutrition screening

    Primary comparison: Prevalence of malnutrition and impact on 30-day outcomes in patients undergoing surgery for cancer

06

What researchers measure

Primary outcomes

  1. Prevalence of malnutrition

    Malnutrition as measured using validated screening tools

    Time frame: Immediately prior to surgery

  2. 30-day mortality rate

    Death within 30 days of surgical procedure

    Time frame: 30 days from surgery

Secondary outcomes

  1. 30-day complication rate

    Defined with by Clavien-Dindo grade III or IV

    Time frame: 30 days from surgery

  2. Length of stay

    Length of hospital admission

    Time frame: 30 days from surgery

  3. Re-operation rate

    Re-operation within 30 days of surgical procedure

    Time frame: 30 days from surgery

  4. Quality of life following surgery (EQ-5D-5L / WHODAS questionnaire (36 item))

    Short-term quality of life for patients following surgery

    Time frame: 30 days from surgery

  5. Readmission rates

    Readmission within 30 days of surgery

    Time frame: 30 days from surgery

  6. Recruitment rate

    Time taken to recruit 200 patients

    Time frame: Through study duration, up to one year

07

Study locations

11 sites
  • Cape Coast Teaching Hospital
    Cape Coast, Ghana
  • Tamale Teaching Hospital
    Tamale, Ghana
  • Tata medical Centre
    Kolkata, India
  • CMC Ludhiana
    Ludhiana, India
  • Padhar Hospital
    Padhar, India
  • AIIMS
    Rishīkesh, India
  • Christian Medical College
    Vellore, India
  • Medical Center
    Manila, Philippines
  • Philippine General Hospital (UP-PGH)
    Manila, Philippines
  • Rizal Medical Center
    Manila, Philippines
  • The Medical City Hospital
    Manila, Philippines
08

References and documents

Individual participant data

Plan to share: Yes — Derived anonymised data at the patient-level may be able to be made available for sharing

Supporting information: Study protocol, Sap, Analytic code

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 7, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04448041
Lead sponsor
University of Edinburgh
Responsible party
Sponsor
First posted
Jun 25, 2020
Start date
Sep 7, 2020
Primary completion
Jun 30, 2021
Completion
Nov 30, 2021
Last update
Jun 7, 2024

Study contacts

Ewen Harrison
principal investigator · University of Edinburgh

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion